Is everyone who could benefit from non-oral therapy receiving them? Know your 10%

12 December, 2017 | Posted in:

by Sue Thomas The Non-Oral Therapy Roadshows have been a great success this year raising awareness of the potential treatments and non-oral pathways for people with Parkinson’s (PwP) who might have more complex therapy needs. Around 10% of each Parkinson’s population may require one of the non-oral therapies, namely apomorphine, deep brain stimulation or duodopa. […]

Continue Reading »

Non-oral therapy roadshows and the relevance of the NICE guidelines for Parkinson’s

12 December, 2017 | Posted in: ,

by Dr Christopher Kobylecki Non-oral therapies for Parkinson’s disease comprise apomorphine infusion, deep brain stimulation (DBS) surgery, and levodopa-carbidopa intestinal gel (LCIG, Duodopa®). Whereas people with Parkinson’s disease typically respond consistently to oral medications for several years, motor fluctuations and levodopa-induced dyskinesia affect half of patients after 4-5 years (1). This heralds the “complex” phase […]

Continue Reading »

Roadshows offer expert half-day training courses

12 September, 2017 | Posted in:

The Parkinson’s Academy roadshows are touring the country again offering expert MasterClass training in one afternoon for busy healthcare professionals. Courses are available on the non-oral therapies for Parkinson’s and non-motor symptoms. Following its success in 2016, the Non-Oral Therapy Roadshow is back on the road. We have re-launched a new series of this regional roadshow which explores […]

Continue Reading »